Sponsor content
336 result(s) found, displaying 71 to 80
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IMJUDO tremelimumab 25 mg/ 1.25 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IMJUDO tremelimumab 300 mg/ 15 mL concentrated injection vial.
-
Prescription medicine decision summaryTruqap (capivasertib), in combination with fulvestrant, is approved for the treatment of adult patients with locally advanced or metastatic breast cancer.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules 500mcg/2ml.
-
-
Prescription medicine decision summaryLokelma (sodium zirconium cyclosilicate hydrate) was approved for the treatment of hyperkalaemia in adult patients. Lokelma binds to potassium in the gut and is used to treat high levels of potassium in the blood.
-
Prescription medicine registrationActive ingredients: dapagliflozin propanediol monohydrate, sitagliptin phosphate monohydrate.
-
Designation or determinationProvisional determination